Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Press
This is some text inside of a div block.
April 5, 2024
Related announcements
Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
